AIAndrey Ivanov

Andrey Ivanov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andrey Ivanov has a total of 4 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • LEFT VENTRICULAR HYPERTROPHY: MECHANISM OF DEVELOPMENT

    by Andrey Ivanov, Elisaveta Levunlieva, Emil Manov, Stefan Najdenov, Nikolay Runev

    Left ventricular hypertrophy (LVH) is an enlargement of the left ventricle caused by chronically increased hemodynamic load, such as arterial hypertension or aortic stenosis. In the initial stages, LVH has a protective nature, but later it can lead to heart failure and arrhythmias. The biochemical mechanisms of hypertrophy involve complex molecular pathways regulating cell proliferation and protein synthesis. These pathways interact through cell surface receptors, transcription factors, and enzymes, leading to structural and functional changes in cardiomyocytes. Changes in the extracellular matrix, inflammatory processes, and oxidative stress play an important role in the transition of hypertrophy from adaptive to pathological stage. Various hormones, vasoactive substances, growth factors, and cytokines are involved in myocardial hypertrophy. Despite significant knowledge concerning signaling pathways related to receptor stimulation, little is still known about the mechanochemical systems that transduce physical signals into cellular responses.

  • ARTERIAL HYPERTENSION: LEFT VENTRICULAR GEOMETRY AND DIASTOLIC DYSFUNCTION

    by Andrey Ivanov, Emil Manov, Stefan Naydenov, Nikolay Runev

    Echocardiography is an established method for assessing left ventricular structure and function in patients with arterial hypertension (AH). Purpose. The study aims to investigate left ventricular geometry and diastolic dysfunction in patients with arterial hypertension and to assess gender-related differences in the established data. Material/methods. A total of 278 individuals were studied, including 30 healthy controls (16 women and 14 men) and 248 patients with arterial hypertension (139 women and 109 men). The echocardiographic examination included M-Mode and B-Mode echocardiography, pulsed-wave spectral Doppler, and pulsed-wave tissue Doppler imaging. Results. Using the criteria of left ventricular mass index (LVMI) > 115 g/m2 in men and LVMI > 95 g/m2 in women for defining left ventricular hypertrophy (LVH), we found LVH in 147 of the hypertensive patients (59.27%). In our patients, LVH was more common in women. LVH was found in 97 women (69.78% of the women with AH) and 50 men (45.87% of the men with AH). One hundred and six (106) patients (42.74%) had no diastolic dysfunction. Grade 1 diastolic dysfunction was found in 95 patients (38.31%), grade 2 in 43 patients (17.34%), and grade 3 in 4 patients (1.61%). Conclusion. In the studied patients with arterial hypertension, a number of echocardiographic indices were found which differed significantly from those in the individuals from the control group. Regular echocardiographic assessment is essential for guiding therapy and reducing the risk in these patients.

  • Open Access

    Mechanism and diagnosis of left ventricular diastolic dysfunction

    by A. Ivanov, E. Levunlieva

    Diastolic dysfunction is a condition in which ventricular fi lling is impaired, regardless of the presence of symptoms and irrespective of whether the ejection fraction is normal or reduced. Left ventricular diastolic dysfunction results from complex and interconnected biochemical and cellular mechanisms. Among them, impaired myocardial relaxation due to calcium dysregulation, altered titin phosphorylation affecting the passive elasticity of the myocardium, and extracellular matrix remodeling with the development of fi brosis mediated by signalling pathways such as TGF-β/SMAD and MAPK play a leading role. Additional contributing factors include oxidative stress and mitochondrial dysfunction, chronic infl ammation and activation of cytokine cascades, metabolic disturbances such as diabetes and obesity, as well as protein dysfunction related to endoplasmic reticulum stress and impaired proteolysis. All these processes in complex lead to impaired diastolic fi lling of the left ventricle, i.e., diastolic dysfunction. Due to its broad availability and proven clinical value, echocardiography is the primary method for diagnosing diastolic dysfunction. Invasive and other imaging modalities offer complementary information in complex or borderline cases, or when echocardiographic evaluation is diffi cult or impossible.